Clinical Trial Update: To Investigate the Effect of Esketamine Hydrochloride on Pulmonary Complications [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of Esketamine Hydrochloride on pulmonary complications is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Valvular Heart Disease

Drugs mentioned

• Esketamine Hydrochloride (esketamine hydrochloride)

Snippet

Sponsor: Zhang XIao Mei | Conditions: Heart Diseases, Heart Valve Diseases | Phase 4 | Status: RECRUITING